Anhedonia (Loss of Pleasure and Motivation): Causes, Link to Depression and What May Help

The classic understanding of anhedonia as ‘the inability to feel pleasure’ turned out to be too simple. Studies in animals and humans suggest that experiencing pleasure and striving for reward rely on partly separate brain systems. Dopamine, popularly called the ‘happiness hormone’, according to many authors is responsible mainly for motivation — the wish to obtain a reward and the effort we are prepared to invest — and not for the sensation of pleasure itself.

This is a theoretical and review paper, so it provides a conceptual framework, not proof that any treatment works. The practical conclusion is nonetheless useful: when talking to a doctor, it is worth describing exactly what has changed. ‘Nothing pleases me, even when I do it’ and ‘I know I used to like running, but I cannot make myself even leave the house’ are different pictures that may steer the diagnosis and the choice of help in different directions.

In depression, anhedonia is linked to changes in the reward system: the ventral striatum, the prefrontal cortex and dopaminergic pathways, as well as chronic activation of the stress axis. Under prolonged tension the brain ‘switches’ to a survival mode in which cognitive resources focus on threats and rewards lose value. This account is mechanistic: it rests on imaging studies, animal models and theory, not on a single validated test that could detect anhedonia in an individual person.

From a psychological perspective a maintaining mechanism is also important: when someone stops doing things that used to bring joy (because they have no energy or do not expect satisfaction), they lose opportunities for positive experiences. Fewer rewards mean less motivation, and less motivation means even less activity. The circle closes and life narrows. It is precisely this circle that behavioural activation, discussed below, aims to break.

Anhedonia is not synonymous with depression. It also occurs in schizophrenia (as part of the negative symptoms), in Parkinson’s disease (where it often coexists with apathy and reduced dopamine in the reward system), in addiction and after stopping substances, in anxiety disorders and post-traumatic stress, and in severe chronic stress and burnout. It may also accompany sleep disorders, chronic illnesses, chronic pain and dementia.

Medication is a topic of its own. SSRI and SNRI antidepressants are effective in depression, but in some people they cause ‘emotional blunting’ — a feeling that both good and bad emotions are muted. A similar effect has been described for some antipsychotics that block dopamine receptors. It is worth distinguishing it from depression itself, because it calls for a different response: a conversation with the doctor about the dose or a change of drug, not stopping it on your own.

This result comes from a survey without randomization, so it cannot establish how much of the blunting is caused by the drug and how much by the illness — and it does not show how often it resolves after a change of treatment. It is, however, enough to say honestly: if after starting an antidepressant you sleep better and suffer less but ‘feel nothing’, this is worth discussing with the doctor and is not a reason for shame or for changing the dose yourself.

Before a lack of joy is attributed to depression, a doctor usually checks simple, reversible causes. We calibrate expectations here: none of them explains anhedonia in most people, but each is cheap to rule out and is treated differently from depression.

We do not recommend testing dopamine ‘on your own’, salivary cortisol or a hormone panel from many laboratories without clinical indications — the results can be hard to interpret and lead to unnecessary treatment.

Among treatments for depression, which is often accompanied by anhedonia, a well-documented and simple-in-principle method is behavioural activation: a therapy of gradually returning, by plan, to activities consistent with one’s own values and offering a chance of reward — instead of waiting for the desire to return. It rests on the observation that motivation often comes after action, not before it.

What follows? Behavioural activation is one of the best-studied and simplest forms of psychotherapy for depression, and its efficacy is comparable with CBT. An important caveat: the studies assessed the severity of depression as a whole, not anhedonia separately, so we do not know whether the method improves the feeling of pleasure to the same degree as mood. It is nonetheless a rational choice for a person whose main problem is passivity and lack of drive.

If symptoms are severe, last longer than two weeks or coexist with other features of depression, self-help should not replace a consultation. Behavioural activation is usually delivered by cognitive behavioural therapists, and for some people combining psychotherapy with medication makes sense — the decision is made together with a doctor or psychiatrist.

What this text does not cover: detailed pharmacological treatment of depression, brain stimulation therapies or newer methods such as ketamine or psilocybin, which are the subject of separate entries in the knowledge base and of research with limited availability. We also do not describe the treatment of anhedonia in schizophrenia and Parkinson’s disease, which requires specialist management.

Anhedonia can be hard to explain to others because it does not hurt and cannot be seen from the outside. The good news is that there are methods that do not require motivation at the start — small, scheduled steps are supported by research on behavioural activation. The bad news: few studies have tested treatment of anhedonia itself, and promises of quick fixes with supplements or ‘dopamine hacks’ have no support in the evidence. A sensible approach combines an honest work-up of causes with psychotherapy and, where necessary, medication.